Results
Revise Search
-
Filters:
- All Records
- 2006
- 2000
- Health information and e-health
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Clinical care to incorporate evidence-based technological advances
https://policybase.cma.ca/en/permalink/policy399
- Last Reviewed
- 2014-03-01
- Date
- 2000-08-16
- Topics
- Health systems, system funding and performance
- Health information and e-health
- Resolution
- GC00-196
- That federal, provincial and territorial governments respond to the health care needs of Canadians by ensuring the provision of clinical care that continually incorporates evidence-based technological advances in information, prevention, and diagnostic and therapeutic services.
- Policy Type
- Policy resolution
- Last Reviewed
- 2014-03-01
- Date
- 2000-08-16
- Resolution
- GC00-196
- That federal, provincial and territorial governments respond to the health care needs of Canadians by ensuring the provision of clinical care that continually incorporates evidence-based technological advances in information, prevention, and diagnostic and therapeutic services.
- Text
- That federal, provincial and territorial governments respond to the health care needs of Canadians by ensuring the provision of clinical care that continually incorporates evidence-based technological advances in information, prevention, and diagnostic and therapeutic services.
Data on maternal morbidity and mortality and infant births and deaths
https://policybase.cma.ca/en/permalink/policy8505
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Population health/ health equity/ public health
- Health information and e-health
- Resolution
- GC06-13
- The Canadian Medical Association and its divisions and affiliates will call on governments to ensure that the data collected on maternal morbidity and mortality and infant births and deaths are comparable across Canada.
- Policy Type
- Policy resolution
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Resolution
- GC06-13
- The Canadian Medical Association and its divisions and affiliates will call on governments to ensure that the data collected on maternal morbidity and mortality and infant births and deaths are comparable across Canada.
- Text
- The Canadian Medical Association and its divisions and affiliates will call on governments to ensure that the data collected on maternal morbidity and mortality and infant births and deaths are comparable across Canada.
Essential drugs for the exclusive use of developing countries
https://policybase.cma.ca/en/permalink/policy415
- Last Reviewed
- 2014-03-01
- Date
- 2000-08-16
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Resolution
- GC00-221
- The CMA calls on governments and pharmaceutical manufacturers in Canada to ensure a supply of essential drugs for the exclusive use of developing countries, and to offset the numerous barriers hindering access to these drugs.
- Policy Type
- Policy resolution
- Last Reviewed
- 2014-03-01
- Date
- 2000-08-16
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Resolution
- GC00-221
- The CMA calls on governments and pharmaceutical manufacturers in Canada to ensure a supply of essential drugs for the exclusive use of developing countries, and to offset the numerous barriers hindering access to these drugs.
- Text
- The CMA calls on governments and pharmaceutical manufacturers in Canada to ensure a supply of essential drugs for the exclusive use of developing countries, and to offset the numerous barriers hindering access to these drugs.
Government funding for health information technology
https://policybase.cma.ca/en/permalink/policy402
- Last Reviewed
- 2014-03-01
- Date
- 2000-08-16
- Topics
- Health information and e-health
- Resolution
- GC00-200
- That the federal, provincial and territorial governments fund the health information technology required to enhance the delivery of quality care and sustain the health care system.
- Policy Type
- Policy resolution
- Last Reviewed
- 2014-03-01
- Date
- 2000-08-16
- Resolution
- GC00-200
- That the federal, provincial and territorial governments fund the health information technology required to enhance the delivery of quality care and sustain the health care system.
- Text
- That the federal, provincial and territorial governments fund the health information technology required to enhance the delivery of quality care and sustain the health care system.
Insurance fund of last resort
https://policybase.cma.ca/en/permalink/policy8520
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Population health/ health equity/ public health
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC06-16
- The Canadian Medical Association urges governments to create an insurance fund of last resort to provide financial relief to parents for the catastrophic cost of drugs and other health care services provided to children as part of an accepted treatment protocol for childhood illnesses and disorders when not covered by public insurance.
- Policy Type
- Policy resolution
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Population health/ health equity/ public health
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC06-16
- The Canadian Medical Association urges governments to create an insurance fund of last resort to provide financial relief to parents for the catastrophic cost of drugs and other health care services provided to children as part of an accepted treatment protocol for childhood illnesses and disorders when not covered by public insurance.
- Text
- The Canadian Medical Association urges governments to create an insurance fund of last resort to provide financial relief to parents for the catastrophic cost of drugs and other health care services provided to children as part of an accepted treatment protocol for childhood illnesses and disorders when not covered by public insurance.
Pharmacists who are given independent prescribing authority
https://policybase.cma.ca/en/permalink/policy8557
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Population health/ health equity/ public health
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Health care and patient safety
- Resolution
- GC06-67
- The Canadian Medical Association, in conjunction with its divisions and affiliates, without endorsing pharmacist independent prescribing strongly urges the Government of Alberta to require pharmacists who are given independent prescribing authority to: a) require explicit, informed consent from a patient; b) maintain a patient's record; c) provide 24-hour availability to the patient; d) carry appropriate coverage for legal liability; e) disclose any potential conflict of interest as both a prescriber and dispenser of medication; and, f) if the pharmacist changes a physician's prescription, advise the physician of the change(s).
- Policy Type
- Policy resolution
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Population health/ health equity/ public health
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Health care and patient safety
- Resolution
- GC06-67
- The Canadian Medical Association, in conjunction with its divisions and affiliates, without endorsing pharmacist independent prescribing strongly urges the Government of Alberta to require pharmacists who are given independent prescribing authority to: a) require explicit, informed consent from a patient; b) maintain a patient's record; c) provide 24-hour availability to the patient; d) carry appropriate coverage for legal liability; e) disclose any potential conflict of interest as both a prescriber and dispenser of medication; and, f) if the pharmacist changes a physician's prescription, advise the physician of the change(s).
- Text
- The Canadian Medical Association, in conjunction with its divisions and affiliates, without endorsing pharmacist independent prescribing strongly urges the Government of Alberta to require pharmacists who are given independent prescribing authority to: a) require explicit, informed consent from a patient; b) maintain a patient's record; c) provide 24-hour availability to the patient; d) carry appropriate coverage for legal liability; e) disclose any potential conflict of interest as both a prescriber and dispenser of medication; and, f) if the pharmacist changes a physician's prescription, advise the physician of the change(s).
Professional development as part of CMA e-strategy
https://policybase.cma.ca/en/permalink/policy468
- Last Reviewed
- 2014-03-01
- Date
- 2000-08-16
- Topics
- Health human resources
- Health information and e-health
- Resolution
- GC00-12
- That General Council endorse Canadian Medical Association's offering of professional development to physicians as part of the Canadian Medical Association's e-strategy.
- Policy Type
- Policy resolution
- Last Reviewed
- 2014-03-01
- Date
- 2000-08-16
- Resolution
- GC00-12
- That General Council endorse Canadian Medical Association's offering of professional development to physicians as part of the Canadian Medical Association's e-strategy.
- Text
- That General Council endorse Canadian Medical Association's offering of professional development to physicians as part of the Canadian Medical Association's e-strategy.
Recommendations pertaining to children's mental health
https://policybase.cma.ca/en/permalink/policy8507
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Health systems, system funding and performance
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Resolution
- GC06-15
- The Canadian Medical Association endorses all of the recommendations pertaining to children's mental health in the Senate report, Out of the Shadows at Last - Transforming Mental Health, Mental Illness and Addiction Services in Canada.
- Policy Type
- Policy resolution
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Health systems, system funding and performance
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Resolution
- GC06-15
- The Canadian Medical Association endorses all of the recommendations pertaining to children's mental health in the Senate report, Out of the Shadows at Last - Transforming Mental Health, Mental Illness and Addiction Services in Canada.
- Text
- The Canadian Medical Association endorses all of the recommendations pertaining to children's mental health in the Senate report, Out of the Shadows at Last - Transforming Mental Health, Mental Illness and Addiction Services in Canada.
Review of the Personal Information Protection and Electronic Documents Act (PIPEDA) : CMA's Presentation to the House of Commons Standing Committee on Access to Information, Privacy and Ethics - December 13, 2006
https://policybase.cma.ca/en/permalink/policy8668
- Last Reviewed
- 2019-03-03
- Date
- 2006-12-13
- Topics
- Health care and patient safety
- Health information and e-health
- Ethics and medical professionalism
1 document
- Policy Type
- Parliamentary submission
- Last Reviewed
- 2019-03-03
- Date
- 2006-12-13
- Topics
- Health care and patient safety
- Health information and e-health
- Ethics and medical professionalism
- Text
- The Canadian Medical Association (CMA) is pleased to be here today to participate in your review of the Personal Information Protection and Electronic Documents Act, or PIPEDA. The CMA has had a long-standing interest in privacy-related matters, including enhancing measures to protect and promote the privacy of health information. We welcome the opportunity to share our policies and thoughts on these vital matters. As a pediatric oncologist from Winnipeg and Chair of the CMA's Committee on Ethics, I come here today with one bottom line: Physicians have always- and continue to - take their patients' privacy very seriously. This is the cornerstone of the special bond between patients and their doctor and has been thus since the time of Hippocrates. In recognition of the importance of privacy, the CMA has produced such documents as the CMA Code of Ethics and the CMA Health Information Privacy Code to guide our more than 64,000 members across the country. These documents existed before the federal government introduced PIPEDA. It is out of our concern for protecting and ensuring the privacy of medical information that we speak to you today. There are three specific areas which we would like to raise: 1) Recognition in law of the unique nature of health care; 2) Physician information as "work product"; and 3) Emerging Privacy and Health information issues. 1. Recognition in law of the unique nature of health care I would like to highlight the importance of recognizing in law the special circumstances of protecting health information. In fact, when PIPEDA was first being debated, CMA posed questions about the scope of the Act and was told that the legislation, originally designed for commerce and the private sector, would not capture health information. We were also told that even if it did, PIPEDA wouldn't change how we practiced medicine. The passing of PIPEDA generated enough concern and uncertainty that government agreed to delay its application to health for 3 years. For example, PIPEDA failed to clarify the issue of implied consent for the sharing of patient information between health professionals providing care. For example, when the family physicians says to a patient "I'm going to send you to see an oncologist to run some tests" and the patient agrees and follows that course of action, then clearly there is "consent" to the sharing of their health information with others. As an oncologist I assume there is consent to send the test results to other specialists that I may need to consult in order to advance the patient's care in a timely fashion. This, however, needed to be addressed before PIPEDA was applied to health care. The delayed application allowed the federal government and health care community to work together and develop a set of guidelines for how PIPEDA would be applied. The resulting PIPEDA Awareness Raising Tools, known as PARTs, contain a series of questions and answers that make up guidelines for health care providers. They answered many of our concerns, provided necessary definitions and allowed for the implied consent model to continue to be used within the circle of care. The CMA applauds the government for this collaborative effort and the resulting guidelines have been used by health care providers ever since. However, we remain concerned that the PARTs guidelines have no legal status. This limitation creates a degree of uncertainty that the CMA would like this legislative review to see addressed by ensuring the PARTs series of questions and answers are referenced in PIPEDA. In addition to participating in the PARTS initiative, since PIPEDA's implementation, the CMA has designed practical tools for physicians and patients: * adopted the CMA policy Principles Concerning Physician Information to address the importance of protecting the privacy of physician information; * produced Privacy in Practice: a handbook for Canadian physicians to help physicians maintain best practices in the protection of patient health information; and * created the PRIVACYWIZARD(tm) designed to help physicians record their current privacy practices, communicate these to patients and identify possible areas for enhancement. 2. Physician Practice Information as "Work Product" I referred earlier to CMA's Policy document on physician information. The CMA strongly believes that physicians have legitimate privacy concerns about the use by third parties of information - such as prescribing and other practice data for commercial purposes. Currently deemed "work product" this information can be collected, used and disclosed without consent. We feel PIPEDA inadequately protects this information. We recognize that it is information generated out of the patient-physician relationship. We disagreed with findings of the previous Privacy Commissioner that physician prescribing information is not subject to PIPEDA's privacy protection provisions for "personal information". The CMA has consistently advocated that physician prescribing data and other practice information is personal information and appeared as an intervener in a Federal Court review of this issue that was ultimately settled by the main parties. Also, insufficient regard for the privacy of prescribing and other physician data could have a negative impact on the sanctity of the physician-patient relationship. Patients confide highly sensitive information to physicians with the expectation this information will be kept in the strictest confidence. This expectation exists because they know that physicians are under ethical and regulatory dictates to safeguard their information and that physicians take this responsibilities very seriously. The perceived and indeed actual loss of control by physicians over information created in the patient encounter, such as prescribing data, could undermine the confidence and faith of our patients that we are able to safeguard their health information. This concern is not hypothetical. For physicians, so called "work product" information also encompasses practice patterns such as discharge rates, referral rates, billing patterns, hospital length of stays, complaints, peer review results, mortality and re-admittance rates. With the advent of electronic medical records and growth in pay-for-performance and outcome-based incentive programs for physicians, there is an enormous potential for the resulting physician "performance" data or "work product" to be "mined" by other parties and used to influence performance review (traditionally the purview of the medical licensing authorities) as well as decisions around treatment funding and system planning. The lack of transparency in the sale and compilation of physicians' prescribing and other performance data means that physicians might find themselves to be the unwitting subject and targets of marketing research. We believe practice decisions must be made in the best interest of patients and not the bottom-line interests of businesses and marketers. CMA therefore recommends a legislative change to include physician information as personal information under PIPEDA. Legislation in Quebec provides an example that is consistent with CMA's approach since it requires regulatory oversight and gives individuals the right to opt out of the collection, use and disclosure of "professional" information. 3. Emerging Privacy and Health information issues With budgetary and demographic pressures, our health care system is under strain and physicians are striving to deliver timely, quality care to patients, often with competing and multiple demands. Physicians are therefore seeking assurances from law makers that any amendments to PIPEDA will take into account the potential impact on them and their patients. Therefore, we seek assurances that: * health care is recognized as unique when it comes to the disclosure of personal information before the transfer of a business (one physician transferring his/her practice to another) because it is regulated at the provincial level through the appropriate licensing body. As a general rule, physicians must give notice to the public, whether via a newspaper ad or a notice in the office about the change in practice. * the federal government will consider the impact of the trans-border flow of personal information on telehealth and Electronic Health Record activities. Communications between patients and physicians via electronic means are likely to increase and to move across geographic boundaries with increasing frequency; and * the federal government will study the issue of international cross border data flows, particularly among Canadian researchers who receive funding from US drug companies. These arrangements should be governed by Canadian law (PIPEDA) not American (HIPAA or the US Patriot Act). In closing, the privacy protection of personal health information is a responsibility that my colleagues and I do not take lightly. It is a key pillar of our relationship with Canadians, they not only expect it-they deserve it. I look forward to taking questions from Committee members. Canadian Medical Association Ottawa, December 13, 2006
Documents
Sale of clove, herbal and vitamin cigarettes
https://policybase.cma.ca/en/permalink/policy8547
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Resolution
- GC06-77
- The Canadian Medical Association will work with the federal government to study the possibility of national legislation governing the promotion and sale of clove, herbal and vitamin cigarettes.
- Policy Type
- Policy resolution
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Resolution
- GC06-77
- The Canadian Medical Association will work with the federal government to study the possibility of national legislation governing the promotion and sale of clove, herbal and vitamin cigarettes.
- Text
- The Canadian Medical Association will work with the federal government to study the possibility of national legislation governing the promotion and sale of clove, herbal and vitamin cigarettes.